Clinical Trials List
2025-07-14 - 2027-08-02
Phase II
Recruiting4
-
Trial Applicant
Boehringer Ingelheim
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- SHUEI-LIONG LIN Division of General Internal Medicine
- CHUN-FU LAI Division of General Internal Medicine
- YU-HSIANG CHOU Division of General Internal Medicine
- VIN-CENT Wu Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Shang-Jyh Hwang Division of Nephrology
- 洪啟智 Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ming-Ju Wu Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
416 participants
